Canada Markets closed

Delcath Systems, Inc. (DCTH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.50-0.39 (-3.94%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close9.89
Bid9.50 x 1800
Ask9.78 x 1000
Day's Range9.41 - 9.99
52 Week Range8.28 - 25.18
Avg. Volume22,623
Market Cap61.488M
Beta (5Y Monthly)0.44
PE Ratio (TTM)N/A
EPS (TTM)-5.13
Earnings DateNov. 09, 2021 - Nov. 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.75
  • Simply Wall St.

    Is Delcath Systems (NASDAQ:DCTH) Weighed On By Its Debt Load?

    Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

  • GlobeNewswire

    Delcath Systems Announces Third Quarter 2021 Results

    NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today reported business highlights and financial results for the third quarter ended September 30, 2021. Recent Business Highlights During and since the third quarter Delcath: Entered a debt facility with Avenue Venture Opportunities Fund, L.P. providing up to $20 million with an initial $15 million fund

  • Zacks

    Delcath Systems, Inc. (DCTH) Stock Jumps 6.6%: Will It Continue to Soar?

    Delcath Systems, Inc. (DCTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.